Complication | Evidence | PMID |
Nephropathy | 1. These findings suggest that hyperglycemia-induced HMGB1 release may induce the renal injury in diabetic rats, and that the pathogenic role of HMGB1 might be dependent on RAGE and through activation of NF-kappa B. | 21606643 |
Cardiovascular | 1. This study demonstrates that increased serum HMGB1 level is associated with CAD in nondiabetic and type 2 diabetic patients. | 19150066 |
Retinopathy | 1. HMGB1 signalling pathway components including receptors for HMGB1 as well as NF-kappaB and TNFalpha/VEGF were significantly upregulated in type 2 diabetic retinas and in high glucose treated ARPE-19 cells, compared to their respective counterparts. | 24133029 |
Neuropathy | 1. These findings suggest that early retinal neuropathy of diabetes involves upregulated expression of HMGB1 and can be ameliorated by inhibition of HMGB1. | 24733965 |
Insulin resistance and inflammation | 1. HMGB1 was secreted from TNF-?-induced 3T3-L1 adipocytes through JNK signaling. HMGB1-activated MAP kinases (ERK1/2, JNK) and suppressed insulin-stimulated Akt phosphorylation in 3T3-L1 adipocytes. | 27430164 |